Glycolaldehyde-derived advanced glycation end products (glycol-AGEs)-induced vascular smooth muscle cell dysfunction is regulated by the AGES-receptor (RAGE) axis in endothelium

References

• Basta G, Lazzerini G, Massaro M, Simoncini T, Tanganelli P, Fu CF, Kislinger T, Stern DM, Schmidt AM, de Caterina R. 2002. Advanced glycation end products activate endothelium through signal-transduction receptor RAGE - a mechanism for amplification of inflammatory responses. Circulation. 105:816–822.
   PubMed Web of Science ®Google Scholar
• Basta G, Schmidt AM, de Caterina R. 2004. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res. 63:582–592.
   PubMed Web of Science ®Google Scholar
• Brasier AR. 2010. The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation. Cardiovasc Res. 86:211–218.
   PubMed Web of Science ®Google Scholar
• Chen Y, Budd RC, Kelm Jr RJ, Sobel BE, Schneider DJ. 2006. Augmentation of proliferation of vascular smooth muscle cells by plasminogen activator inhibitor type 1. Arterioscler Thromb Vasc Biol. 26:1777–1783.
   PubMed Web of Science ®Google Scholar
• Chistiakov DA, Orekhov AN, Bobryshev YV. 2015. Vascular smooth muscle cell in atherosclerosis. Acta Physiol (Oxf). 214:33–50.
   PubMed Web of Science ®Google Scholar
• Cho A, Graves J, Reidy MA. 2000. Mitogen-activated protein kinases mediate matrix metalloproteinase-9 expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 20:2527–2532.
   PubMed Web of Science ®Google Scholar
• Cullen JP, Sayeed S, Kim Y, Theodorakis NG, Sitzmann JV, Cahill PA, Redmond EM. 2005. Ethanol inhibits pulse pressure-induced vascular smooth muscle cell migration by differentially modulating plasminogen activator inhibitor type 1, matrix metalloproteinase-2 and -9. Thromb Haemost. 94:639–645.
   PubMed Web of Science ®Google Scholar
• Davignon J, Ganz P. 2004. Role of endothelial dysfunction in atherosclerosis. Circulation. 109:III27–III32.
   PubMed Web of Science ®Google Scholar
• DeYoung MB, Tom C, Dichek DA. 2001. Plasminogen activator inhibitor type 1 increases neointima formation in balloon-injured rat carotid arteries. Circulation. 104:1972–1977.
   PubMed Web of Science ®Google Scholar
• Galis ZS, Johnson C, Godin D, Magid R, Shipley JM, Senior RM, Ivan E. 2002. Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling. Circ Res. 91:852–859.
   PubMed Web of Science ®Google Scholar
• Gallicchio M, Argyriou S, Ianches G, Filonzi EL, Zoellner H, Hamilton JA, Mcgrath K, Wojta J. 1994. Stimulation of PAI-1 expression in endothelial cells by cultured vascular smooth muscle cells. Arterioscler Thromb. 14:815–823.
   PubMedGoogle Scholar
• Gao X, Zhang H, Schmidt AM, Zhang C. 2008. AGE/RAGE produces endothelial dysfunction in coronary arterioles in type 2 diabetic mice. Am J Physiol Heart Circ Physiol. 295:H491–H498.
   PubMed Web of Science ®Google Scholar
• Goldin A, Beckman JA, Schmidt AM, Creager MA. 2006. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation. 114:597–605.
   PubMed Web of Science ®Google Scholar
• Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, Libby P, Rollins BJ. 1998. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell. 2:275–281.
   PubMed Web of Science ®Google Scholar
• Hattori Y, Suzuki M, Hattori S, Kasai K. 2002. Vascular smooth muscle cell activation by glycated albumin (Amadori adducts). Hypertension. 39:22–28.
   PubMed Web of Science ®Google Scholar
• Kaplanski G, Marin V, Fabrigoule M, Boulay V, Benoliel AM, Bongrand P, Kaplanski S, Farnarier C. 1998. Thrombin-activated human endothelial cells support monocyte adhesion in vitro following expression of intercellular adhesion molecule-1 (ICAM-1; CD54) and vascular cell adhesion molecule-1 (VCAM-1; CD106). Blood. 92:1259–1267.
   PubMed Web of Science ®Google Scholar
• Kume N, Moriwaki H, Kataoka H, Minami M, Murase T, Sawamura T, Masaki T, Kita T. 2000. Inducible expression of LOX-1, a novel receptor for oxidized LDL, in macrophages and vascular smooth muscle cells. Ann N Y Acad Sci. 902:323–327.
   PubMed Web of Science ®Google Scholar
• Lacolley P, Regnault V, Nicoletti A, Li Z, Michel JB. 2012. The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles. Cardiovasc Res. 95:194–204.
   PubMed Web of Science ®Google Scholar
• Lee B, Moon SK. 2005. Resveratrol inhibits TNF-alpha-induced proliferation and matrix metalloproteinase expression in human vascular smooth muscle cells. J Nutr. 135:2767–2773.
   PubMed Web of Science ®Google Scholar
• Lee E, Grodzinsky AJ, Libby P, Clinton SK, Lark MW, Lee RT. 1995. Human vascular smooth muscle cell-monocyte interactions and metalloproteinase secretion in culture. Arterioscler Thromb Vasc Biol. 15:2284–2289.
   PubMed Web of Science ®Google Scholar
• Lee IT, Shih RH, Lin CC, Chen JT, Yang CM. 2012. Role of TLR4/NADPH oxidase/ROS-activated p38 MAPK in VCAM-1 expression induced by lipopolysaccharide in human renal mesangial cells. Cell Commun Signal. 10: 33.
   PubMed Web of Science ®Google Scholar
• Libby P. 2012. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol. 32:2045–2051.
   PubMed Web of Science ®Google Scholar
• Lukacs NW, Strieter RM, Elner V, Evanoff HL, Burdick MD, Kunkel SL. 1995. Production of chemokines, interleukin-8 and monocyte chemoattractant protein-1, during monocyte endothelial-cell interactions. Blood. 86:2767–2773.
   PubMed Web of Science ®Google Scholar
• Maruyama I, Shigeta K, Miyahara H, Nakajima T, Shin H, Ide S, Kitajima I. 1997. Thrombin activates NF-kappa B through thrombin receptor and results in proliferation of vascular smooth muscle cells: role of thrombin in atherosclerosis and restenosis. Ann N Y Acad Sci. 811:429–436.
   PubMed Web of Science ®Google Scholar
• Moon SK, Cha BY, Kim CH. 2004. ERK1/2 mediates TNF-alpha-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-kappaB and AP-1: involvement of the Ras dependent pathway. J Cell Physiol. 198:417–427.
   PubMed Web of Science ®Google Scholar
• Moon SK, Cho GO, Jung SY, Gal SW, Kwon TK, Lee YC, Madamanchi NR, Kim CH. 2003. Quercetin exerts multiple inhibitory effects on vascular smooth muscle cells: role of ERK1/2, cell-cycle regulation, and matrix metalloproteinase-9. Biochem Biophys Res Commun. 301:1069–1078.
   PubMed Web of Science ®Google Scholar
• Morigi M, Macconi D, Zoja C, Donadelli R, Buelli S, Zanchi C, Ghilardi M, Remuzzi G. 2002. Protein overload-induced NF-kappaB activation in proximal tubular cells requires H(2)O(2) through a PKC-dependent pathway. J Am Soc Nephrol. 13:1179–1189.
   PubMed Web of Science ®Google Scholar
• Mudau M, Genis A, Lochner A, Strijdom H. 2012. Endothelial dysfunction: the early predictor of atherosclerosis. Cardiovasc J Afr. 23:222–231.
   PubMed Web of Science ®Google Scholar
• Nam MH, Lee HS, Seomun Y, Lee Y, Lee KW. 2011. Monocyte-endothelium-smooth muscle cell interaction in co-culture: proliferation and cytokine productions in response to advanced glycation end products. Biochim Biophys Acta. 1810:907–912.
   PubMed Web of Science ®Google Scholar
• Ott C, Jacobs K, Haucke E, Santos AN, Grune T, Simm A. 2014. Role of advanced glycation end products in cellular signaling. Redox Biol. 2:411–429.
   PubMed Web of Science ®Google Scholar
• Puddu P, Puddu GM, Cravero E, Rosati M, Muscari A. 2008. The molecular sources of reactive oxygen species in hypertension. Blood Press. 17:70–77.
   PubMed Web of Science ®Google Scholar
• Riganti C, Costamagna C, Doublier S, Miraglia E, Polimeni M, Bosia A, Ghigo D. 2008. The NADPH oxidase inhibitor apocynin induces nitric oxide synthesis via oxidative stress. Toxicol Appl Pharmacol. 228:277–285.
   PubMed Web of Science ®Google Scholar
• Rodriguez JA, Orbe J, Paramo JA. 2007. Metalloproteases, vascular remodeling and atherothrombotic syndromes. Rev Esp Cardiol. 60:959–967.
   PubMed Web of Science ®Google Scholar
• Ross R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:801–809.
   PubMed Web of Science ®Google Scholar
• Sakata N, Meng J, Takebayashi S. 2000. Effects of advanced glycation end products on the proliferation and fibronectin production of smooth muscle cells. J Atheroscler Thromb. 7:169–176.
   PubMedGoogle Scholar
• Schildberger A, Rossmanith E, Eichhorn T, Strassl K, Weber V. 2013. Monocytes, peripheral blood mononuclear cells, and THP-1 cells exhibit different cytokine expression patterns following stimulation with lipopolysaccharide. Mediators Inflamm. 2013:697972.
   PubMed Web of Science ®Google Scholar
• Siebenlist U, Franzoso G, Brown K. 1994. Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol. 10:405–455.
   PubMedGoogle Scholar
• Sitia S, Tomasoni L, Atzeni F, Ambrosio G, Cordiano C, Catapano A, Tramontana S, Perticone F, Naccarato P, Camici P, et al. 2010. From endothelial dysfunction to atherosclerosis. Autoimmun Rev. 9:830–834. ]
   PubMed Web of Science ®Google Scholar
• Stern D, Yan SD, Yan SF, Schmidt AM. 2002. Receptor for advanced glycation end products: a multiligand receptor magnifying cell stress in diverse pathologic settings. Adv Drug Deliv Rev. 54:1615–1625.
   PubMed Web of Science ®Google Scholar
• Tsouknos A, Nash GB, Rainger GE. 2003. Monocytes initiate a cycle of leukocyte recruitment when cocultured with endothelial cells. Atherosclerosis. 170:49–58.
   PubMed Web of Science ®Google Scholar
• Wautier MP, Chappey O, Corda S, Stern DM, Schmidt AM, Wautier J-L. 2001. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab. 280:E685–E694.
   PubMed Web of Science ®Google Scholar
• Wu X, Zhou Q, Huang L, Sun A, Wang K, Zou Y, Ge J. 2008. Ageing-exaggerated proliferation of vascular smooth muscle cells is related to attenuation of Jagged1 expression in endothelial cells. Cardiovasc Res. 77:800–808.
   PubMed Web of Science ®Google Scholar
• Yu L, Zhao Y, Xu S, Ding F, Jin C, Fu G, Weng S. 2013. Advanced glycation end product (AGE)-AGE receptor (RAGE) system upregulated Connexin43 expression in rat cardiomyocytes via PKC and Erk MAPK pathways. Int J Mol Sci. 14:2242–2257.
   PubMed Web of Science ®Google Scholar
• Zhao W, Ma G, Chen X. 2014. Lipopolysaccharide induced LOX-1 expression via TLR4/MyD88/ROS activated p38MAPK-NF-κB pathway. Vascul Pharmacol. 63:162–172.
   PubMed Web of Science ®Google Scholar